Title: Treatment discontinuation and clinical outcomes in the 1-year naturalistic treatment of patients with schizophrenia at risk of treatment nonadherence
Authors: last_name: Kelin
first_name: Katarina
name: Katarina Kelin
affiliations: label: 1
name: Eli Lilly Australia Pty Ltd, West Ryde, NSW, Australia;
last_name: Lambert
first_name: Timothy JR
name: Timothy JR Lambert
affiliations: label: 2
name: Discipline of Psychiatry, Brain and Mind Research Institute, The University of Sydney, Camperdown, NSW, Australia;
last_name: Brnabic
first_name: Alan JM
name: Alan JM Brnabic
affiliations: label: 3
name: Intercontinental Information Sciences, Eli Lilly Australia Pty Ltd, Macquarie Park, NSW, Australia;
last_name: Newton
first_name: Richard
name: Richard Newton
affiliations: label: 4
name: Peninsula Health Psychiatric Services, Frankston Hospital, Frankston, VIC, Australia (current affiliation: Department of Psychiatry, Austin Hospital, Heidelberg, VIC, Australia);
last_name: Ye
first_name: Wendy
name: Wendy Ye
affiliations: label: 3
name: Intercontinental Information Sciences, Eli Lilly Australia Pty Ltd, Macquarie Park, NSW, Australia;
last_name: Escamilla
first_name: Raúl I
name: Raúl I Escamilla
affiliations: label: 5
name: Schizophrenia Clinic, National Institute of Psychiatry, Mexico City, Mexico;
last_name: Chen
first_name: Kuang-Peng
name: Kuang-Peng Chen
affiliations: label: 6
name: Department of Psychiatry, National Taiwan University Hospital, Yun-Lin, Taiwan;
last_name: Don
first_name: Liana
name: Liana Don
affiliations: label: 7
name: Department of Psychiatry, University of Medicine Iuliu Hatieganu Cluj Napoca, Romania;
last_name: Montgomery
first_name: William
name: William Montgomery
affiliations: label: 1
name: Eli Lilly Australia Pty Ltd, West Ryde, NSW, Australia;
last_name: Karagianis
first_name: Jamie
name: Jamie Karagianis
affiliations: label: 8
name: Lilly USA, Eli Lilly and Company, Indianapolis, IN, USA;
last_name: Ascher-Svanum
first_name: Haya
name: Haya Ascher-Svanum
affiliations: label: 9
name: Global Health Outcomes, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA
Affiliations: label: 1
name: Eli Lilly Australia Pty Ltd, West Ryde, NSW, Australia;
label: 2
name: Discipline of Psychiatry, Brain and Mind Research Institute, The University of Sydney, Camperdown, NSW, Australia;
label: 3
name: Intercontinental Information Sciences, Eli Lilly Australia Pty Ltd, Macquarie Park, NSW, Australia;
label: 4
name: Peninsula Health Psychiatric Services, Frankston Hospital, Frankston, VIC, Australia (current affiliation: Department of Psychiatry, Austin Hospital, Heidelberg, VIC, Australia);
label: 5
name: Schizophrenia Clinic, National Institute of Psychiatry, Mexico City, Mexico;
label: 6
name: Department of Psychiatry, National Taiwan University Hospital, Yun-Lin, Taiwan;
label: 7
name: Department of Psychiatry, University of Medicine Iuliu Hatieganu Cluj Napoca, Romania;
label: 8
name: Lilly USA, Eli Lilly and Company, Indianapolis, IN, USA;
label: 9
name: Global Health Outcomes, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA
Field: Medicine
Document type: article
Year: 2011